B.S. Kim

A phase II study of capecitabine plus 3-weekly oxaliplatin as first-line therapy for patients with advanced gastric cancer

Young-Ae Park, B. Ryoo, S. Yang, 2006, British Journal of Cancer.

A phase II trial of DA-125, a novel anthracycline, in advanced non-small-cell lung cancer

B. Ryoo, T. Kim, Y. Im, 1999, Cancer Chemotherapy and Pharmacology.